{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:30:01Z","timestamp":1790094601978,"version":"4.0.1"},"reference-count":93,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Ankylosing spondylitis (AS) is a common immune\u2010mediated inflammatory arthritis with a strong genetic predisposition. We review recent data from genetic and animal studies highlighting the importance of Type 17 immune responses. Furthermore, the efficacy (or lack thereof) of different anti\u2010cytokine monoclonal antibodies has highlighted the diversity of Type 17 immune cells and cytokines critical to AS and related spondyloarthritis pathogenesis. Recent studies have strongly implicated the gut microbiome in AS. Finally, we propose that the local metabolic environment of the joint may have a key role in driving AS, and present a novel model of AS pathogenesis.<\/jats:p>","DOI":"10.1111\/imm.13242","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T08:59:30Z","timestamp":1595408370000},"page":"94-102","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["New developments in our understanding of ankylosing spondylitis pathogenesis"],"prefix":"10.1111","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2399-5656","authenticated-orcid":false,"given":"Aniruddha","family":"Voruganti","sequence":"first","affiliation":[{"name":"Exeter College University of Oxford Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bowness","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Science (NDORMS) Botnar Research Centre University of Oxford Headington Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-019-0057-8"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.104018"},{"key":"e_1_2_14_5_1","unstructured":"Recommendations | Spondyloarthritis in over 16s: diagnosis and management | Guidance | NICE [Internet].NICE. [WWW document]. URLhttps:\/\/www.nice.org.uk\/guidance\/NG65\/chapter\/Recommendations#pharmacological\u2010management\u2010of\u2010spondyloarthritis[cited on 8 April 2020]"},{"key":"e_1_2_14_6_1","unstructured":"Ankylosing spondylitis \u2013 treatment [Internet].2017. URLhttps:\/\/www.nhs.uk\/conditions\/ankylosing\u2010spondylitis\/treatment\/[cited on 8 April 2020]"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401015"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)91360-3"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket387"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8146"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032414-112110"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1309781110"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.133"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38809"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200635997"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102711"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002653"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2667"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3528"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2007.17"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.873"},{"key":"e_1_2_14_22_1","unstructured":"NICE.Overview | TNF\u2010alpha inhibitors for ankylosing spondylitis and non\u2010radiographic axial spondyloarthritis | Guidance | NICE [Internet]. URLhttps:\/\/www.nice.org.uk\/guidance\/ta383[cited on 8 April 2020]"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20852"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21913"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204231"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.154799"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350911"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0091-8"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01771-2"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3432"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38647"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24599"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90512-D"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.03.009"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2817"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39732"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2014.976630"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-009-0166-0"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.11.009"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2416"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.060293"},{"key":"e_1_2_14_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0744-2"},{"key":"e_1_2_14_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006634"},{"key":"e_1_2_14_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39464"},{"key":"e_1_2_14_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.10.039"},{"key":"e_1_2_14_46_1","first-page":"419","article-title":"Gender\u2010attributable differences in outcome of ankylosing spondylitis: long\u2010term results from the Outcome in Ankylosing Spondylitis International Study","volume":"55","author":"Webers C","year":"2016","journal-title":"Rheumatology"},{"key":"e_1_2_14_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1647-4"},{"key":"e_1_2_14_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3370"},{"key":"e_1_2_14_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.33507"},{"key":"e_1_2_14_50_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031000"},{"key":"e_1_2_14_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61134-4"},{"key":"e_1_2_14_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505066"},{"key":"e_1_2_14_53_1","unstructured":"NICE.Overview | Secukinumab for active ankylosing spondylitis after treatment with non\u2010steroidal anti\u2010inflammatory drugs or TNF\u2010alpha inhibitors | Guidance | NICE [Internet]. URLhttps:\/\/www.nice.org.uk\/guidance\/ta407[cited on 10 April 2020]"},{"key":"e_1_2_14_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9774-0"},{"key":"e_1_2_14_55_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5703"},{"key":"e_1_2_14_56_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.6.2593"},{"key":"e_1_2_14_57_1","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.4049\/jimmunol.161.11.6383","article-title":"IL\u201017 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy\u2010derived method for in vivo evaluation of cytokines","volume":"161","author":"Schwarzenberger P","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_14_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13853-4"},{"key":"e_1_2_14_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2031"},{"key":"e_1_2_14_60_1","unstructured":"Efficacy and Safety of Namilumab for Moderate\u2010to\u2010severe Axial Spondyloarthritis \u2010 Full Text View \u2010 ClinicalTrials.gov [Internet]. URLhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT03622658[cited on 10 April 2020]"},{"key":"e_1_2_14_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204248"},{"key":"e_1_2_14_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40728"},{"key":"e_1_2_14_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213328"},{"key":"e_1_2_14_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213654"},{"key":"e_1_2_14_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215210"},{"key":"e_1_2_14_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-011-0202-x"},{"key":"e_1_2_14_67_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203643"},{"key":"e_1_2_14_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06933-4"},{"key":"e_1_2_14_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201915"},{"key":"e_1_2_14_70_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140647"},{"key":"e_1_2_14_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32463-2"},{"key":"e_1_2_14_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3691"},{"key":"e_1_2_14_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key070"},{"key":"e_1_2_14_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34026-1"},{"key":"e_1_2_14_75_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126567"},{"key":"e_1_2_14_76_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210322"},{"key":"e_1_2_14_77_1","first-page":"394","article-title":"Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease","volume":"18","author":"Mielants H","year":"1991","journal-title":"J Rheumatol"},{"key":"e_1_2_14_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24389"},{"key":"e_1_2_14_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2014.10.018"},{"key":"e_1_2_14_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38967"},{"key":"e_1_2_14_81_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215763"},{"key":"e_1_2_14_82_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1617460113"},{"key":"e_1_2_14_83_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214381"},{"key":"e_1_2_14_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40917"},{"key":"e_1_2_14_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101499"},{"key":"e_1_2_14_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11984"},{"key":"e_1_2_14_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature24628"},{"key":"e_1_2_14_88_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1145697"},{"key":"e_1_2_14_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature06878"},{"key":"e_1_2_14_90_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13783"},{"key":"e_1_2_14_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1785-z"},{"key":"e_1_2_14_92_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key001"},{"key":"e_1_2_14_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23291"},{"key":"e_1_2_14_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature23475"}],"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fimm.13242","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imm.13242","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/imm.13242","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imm.13242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T03:43:01Z","timestamp":1693885381000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imm.13242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1111\/imm.13242"],"URL":"https:\/\/doi.org\/10.1111\/imm.13242","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"2020-05-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}